Navigation Links
LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors
Date:5/27/2009

AUSTIN, Texas; PHILADELPHIA The Lance Armstrong Foundation (LAF) and Penn Medicine announced today a four-year partnership to further develop and disseminate the LIVESTRONG Care Plan Powered by Penn Medicine's OncoLink. This free service gives cancer survivors, their families and physicians the ability to create an individualized plan of care using up-to-date treatment information based on Institute of Medicine recommendations, as well educating them about their options to maintain optimal health once they are out of treatment.

The LIVESTRONG Care Plan assists adults diagnosed with cancer in understanding and planning for such issues as: potential late effects of treatment; recommendations for cancer screening (recurrence or new primary); psychosocial effects (including relationships and sexuality/fertility); recommendations for a healthy lifestyle; genetic counseling (if appropriate); effective prevention options; and a list of resources made available through the LIVESTRONG cancer survivorship support services.

"There are currently 12 million cancer survivors in the United States and 28 million worldwide," said Doug Ulman, President and CEO of the Lance Armstrong Foundation. "The lack of post-cancer medical care leaves a staggering number of people without support. The LIVESTRONG Care Plan is a simple, easily accessible resource to help people manage the ongoing effects of cancer treatments, communicate with their medical team and get the support they need in all aspects of their fight."

Originally launched as OncoLife on Penn Medicine's OncoLink website in 2007, the tool is the only one of its kind, created and updated continuously by a team of cancer physicians and nurses. With its transition to the LIVESTRONG Care Plan, it will be able to reach tens of thousands of additional cancer survivors, their friends, families and health care providers through the LAF's many supportive activities and programs. Available in Spanish as we
'/>"/>

Contact: Marc Kaplan
marc.kaplan@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Lance Armstrong Marks 5th Annual LIVESTRONG(TM) Day with Nationwide Fly-Around
2. LIVESTRONG.COM Survey Reveals 86 Percent of Americans Attempt Changes to Improve Their Health but Less Than Half are Successful
3. Lance Armstrong Foundation and Demand Media Launch LIVESTRONG.COM
4. Lance Armstrong Foundation to Welcome Senator John McCain to LIVESTRONG(TM) Cancer Summit
5. Lance Armstrong Foundation Selects Ogilvy Public Relations Worldwide to Support the LIVESTRONG Global Cancer Campaign
6. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
7. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
8. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
9. £5 million investment in personalized medicines to cut patient deaths
10. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News: AdvancedMD Software Names Tech Veteran, Christopher J. Bijou, as Executive Vice President of Sales : Executive to Drive Growth of Software as a Service for Medical Practice Management Industry 2Health News: AdvancedMD Software Names Tech Veteran, Christopher J. Bijou, as Executive Vice President of Sales : Executive to Drive Growth of Software as a Service for Medical Practice Management Industry 3Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 2Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 3Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 4Health News:Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels 5Health News:Sex difference on spatial skill test linked to brain structure 2Health News:FloBeds Develops Nation's First 'For Women Only' Mattress 2Health News:Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award 2Health News:Missouri Behavioral Pharmacy Management Program Receives 2008 SAMHSA Science and Service Award 3Health News:Annals colonoscopy study underscores importance of quality standards 2